A groundbreaking shift in our drug policy has happened, as the authorities allow the use of psilocybin hallucinogens for therapeutic purposes. Before this, these substances were heavily restricted, but a mounting body of evidence suggests they could offer benefits for emotional conditions like anxiety. The new policy represents a major step toward